0000886163-19-000080.txt : 20190514 0000886163-19-000080.hdr.sgml : 20190514 20190514195651 ACCESSION NUMBER: 0000886163-19-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190514 FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOZARICH JOHN W CENTRAL INDEX KEY: 0001223000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 19824671 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-05-14 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001223000 KOZARICH JOHN W 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2019-05-14 4 M 0 2500 17.88 A 28042 D Common Stock 2019-05-14 4 S 0 2500 112.92 D 25542 D Non-Qualified Stock Option (right to buy) 17.88 2019-05-14 2019-05-14 4 M 0 2500 0.0 D 2019-05-29 Common Stock 2500 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.24 to $113.23, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option becomes exercisable in twelve successive equal monthly installments upon completion of each calendar month of service beginning 5/29/09. By: Charles S. Berkman For: John W. Kozarich 2019-05-14